The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...

Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

Novartis (NVS) announced positive results from KALUMA, a Phase III study for new malaria treatment KLU156. The novel non-artemisinin antimalarial, ...

Shawmut Corporation, a global leader in advanced materials and high-performance textiles announces the launch of Shawmut Insights(TM), a proprietary Life Cycle Assessment (LCA) system that delivers ...

The United States Tumor Profiling Market is projected to surge from US$ 3.41 billion in 2024 to US$ 7.44 billion by 2033, ...

Developed in-house and designed specifically for textile markets, Shawmut Insights is among the first LCA systems capable of ...

Throughout the Global South, informal recyclers—waste pickers, co-ops and buy-back centres—recover PET, HDPE, aluminium and ...

The transcription factor HEB synergizes with TCR signaling to upregulate Id3, which is required for the maturation of fetal IL-17-producing γδ T cells.

Discover how Artificial Intelligence is transforming mobile app development in 2026 with trends like hyper-personalization, ...

This study shows that excitatory cholecystokinin (CCK)-expressing neurons in hippocampal area CA3 influence hippocampal-dependent memory using multiple methods to manipulate excitatory CCK-expressing ...